Skip to NavigationSkip to content

News

0
Top Ten most popular articles on Pharmafile.com this week
Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared with 2018, while...
0
European Commission expands Stelara for paediatric moderate to severe plaque psoriasis
Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis in children...
0
FDA puts MDMA therapy for PTSD on its Expanded Access program
The FDA has made MDMA treatment for PTSD more accessible by putting it on its Expanded Access program.
0
Roche's Tecentriq falls short as an adjuvant monotherapy in muscle-invasive urothelial cancer
Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed to meet its...
>> More News Stories

Features

Collaborating to realise the potential of precision medicine

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the industry...

>> More Features
>> More News Stories